Skip to main content

Table 1 characteristics of R/R AML

From: Naturally selected CD7 CAR-T therapy without genetic editing demonstrates significant antitumour efficacy against relapsed and refractory acute myeloid leukaemia (R/R-AML)

Sample ID

Age

Sex

CD7 + 

Cytogenetics

1

42

F

Neg

46, XX

2

57

M

Neg

46, XY

3

73

F

79.78%

46, XX

4

67

M

31.38%

46, XY

5

32

F

Neg

46, XX

6

64

F

Neg

46, XX

7

73

M

79.96%

46, XY, del (9) (q22; q34)

8

30

M

Neg

46, XY, t (8;21) (q22; q22)

9

16

M

Neg

45, X, -Y, t (8;21) (q22; q22)

10

71

F

Neg

46, XX

11

34

F

60.75%

46, XX

12

41

M

Neg

47, XY, + 8

13

59

M

5.00%

46, XY

14

66

M

Neg

46, XY

15

65

F

Neg

Complex

16

37

M

Neg

Complex